Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns

Authors :: Heather A. Jacene
Jacek Capala
Babak Saboury
Daniel A. Pryma
Amir Iravani
Richard L. Wahl
Stephen A. Graves
George Sgouros
Source :: Journal of Nuclear Medicine. 62:23S-35S
Publication Year :: 2021
Publisher :: Society of Nuclear Medicine, 2021.
Abstract: Radiopharmaceutical therapies are gaining increasing prominence as they improve survival in patients with common diseases such as metastatic prostate cancer ([ 1 ][1],[ 2 ][2]). However, whereas sodium iodide (131I) therapy has been used for over 70 y in treating malignant and benign thyroid

Subjects :: medicine.medical_specialty
business.industry
Thyroid
Normal tissue
Urology
medicine.disease
chemistry.chemical_compound
Prostate cancer
medicine.anatomical_structure
chemistry
Sodium iodide
medicine
Radiology, Nuclear Medicine and imaging
In patient
Radiopharmaceuticals
business

Tools